3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum
- PMID: 10632901
- DOI: 10.1046/j.1365-2990.1999.00212.x
3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum
Abstract
Systemic administration of the mitochondrial toxin 3-nitropropionic acid (3-NP) to rats results in selective striatal lesions and serves as an experimental model of Huntington's disease (HD). However, the effects of the 3-NP treatment are unpredictable and result in lesions of variable severity. The present study was aimed at further characterizing the variability of the striatal lesions induced by systemic administration of 3-NP using osmotic pumps. Hematoxylin-eosin (HE) and Nissl stains as well as immunohistochemical labelling of astrocytes and striatal neurones were performed to analyse the neurotoxic effects of 3-NP. In general, chronic systemic administration of 3-NP resulted in obvious bilateral striatal lesions, which ranged from mild to severe, together with a subtle, but detectable behavioural lesion. Severe type lesions showed marked neuronal loss and an increased expression of glial fibrillary acidic protein (GFAP) in astrocytes surrounding the lesion area, whereas in the core of the lesion GFAP-immunoreactivity was absent. The mild type lesion was characterized by a substantial loss of striatal neurones and an increased expression of GFAP-positive astrocytes throughout the lesion. In a number of 3-NP-treated animals, neither type of lesion was observed, although these animals demonstrated behavioural changes in the paw test compared to controls. In the striatum of these tested 3-NP-treated animals, compromised rk' neurones were detected, suggestive of subtle and early 3-NP-induced neuronal injury. Similar dark neurones were also detected in mild and severe lesions and were immunocytochemically characterized as gamma-aminobutyric acid (GABA) and substance P containing spiny neurones, which belong to the neuronal population that is affected in early HD. These results indicate that systemic administration of 3-NP to rats may result in a spectrum of striatal pathology of which the morphology of the mild type lesion resembles the characteristic HD neuropathology most closely.
Similar articles
-
Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.Neuroscience. 1997 Jul;79(1):45-56. doi: 10.1016/s0306-4522(96)00602-1. Neuroscience. 1997. PMID: 9178864
-
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid.J Neurosci. 1993 Oct;13(10):4181-92. doi: 10.1523/JNEUROSCI.13-10-04181.1993. J Neurosci. 1993. PMID: 7692009 Free PMC article.
-
The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum.Neuropathol Appl Neurobiol. 2001 Feb;27(1):68-76. doi: 10.1046/j.0305-1846.2001.00305.x. Neuropathol Appl Neurobiol. 2001. PMID: 11299004
-
Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation.Neurosci Res. 1997 Jul;28(3):185-9. doi: 10.1016/s0168-0102(97)00045-x. Neurosci Res. 1997. PMID: 9237266 Review.
-
3-Nitropropionic acid animal model and Huntington's disease.Neurosci Biobehav Rev. 1997 May;21(3):289-93. doi: 10.1016/s0149-7634(96)00027-9. Neurosci Biobehav Rev. 1997. PMID: 9168265 Review.
Cited by
-
Parthenolide ameliorates 3-nitropropionic acid-induced Huntington's disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting.Mol Med. 2024 Sep 26;30(1):158. doi: 10.1186/s10020-024-00917-5. Mol Med. 2024. PMID: 39327568 Free PMC article.
-
Current and Possible Future Therapeutic Options for Huntington's Disease.J Cent Nerv Syst Dis. 2022 May 21;14:11795735221092517. doi: 10.1177/11795735221092517. eCollection 2022. J Cent Nerv Syst Dis. 2022. PMID: 35615642 Free PMC article. Review.
-
Increased Expression of Osteopontin in the Degenerating Striatum of Rats Treated with Mitochondrial Toxin 3-Nitropropionic Acid: A Light and Electron Microscopy Study.Acta Histochem Cytochem. 2015 Oct 29;48(5):135-43. doi: 10.1267/ahc.15010. Epub 2015 Oct 21. Acta Histochem Cytochem. 2015. PMID: 26633905 Free PMC article.
-
Rescuing neuronal cell death by RAIDD- and PIDD- derived peptides and its implications for therapeutic intervention in neurodegenerative diseases.Sci Rep. 2016 Aug 9;6:31198. doi: 10.1038/srep31198. Sci Rep. 2016. PMID: 27502430 Free PMC article.
-
Nicotinamide reverses behavioral impairments and provides neuroprotection in 3-nitropropionic acid induced animal model ofHuntington's disease: implication of oxidative stress- poly(ADP- ribose) polymerase pathway.Metab Brain Dis. 2018 Dec;33(6):1911-1921. doi: 10.1007/s11011-018-0297-0. Epub 2018 Jul 27. Metab Brain Dis. 2018. PMID: 30054774
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous